Industry News
Pharmaceutical Industry News
Trump’s Takeover of the Republican Party
Readers discuss a column by David Brooks. Also: Tears for America; the border reform bill; FAFSA delays; an Alzheimer’s drug; protests in Israel.
Don Catlin, Who Ran an Elite Antidoping Laboratory, Dies at 85
A medical doctor and an expert in pharmacology, he ran drug testing for sports leagues and the Olympics, unlocking the chemical codes for previously undetectable designer steroids.
Is It Possible to Reverse the Dark Circles Under My Eyes?
Some skin care products can offer some benefits, but they may not live up to their brightening claims.
US Agencies Start Inquiry Into Generic Drug Shortages
The F.T.C. and H.H.S. are examining the tactics of group purchasing organizations that generic industry executives say have led to scarce supplies of treatments like chemotherapy.
Journal Retracts Studies Cited in Federal Court Ruling Against Abortion Pill
The journal found that the studies, which had suggested that medication abortion is unsafe, included incorrect factual assumptions and misleading presentation of the data.
J&J, Merck and Bristol Myers Squibb CEOs Testify at Senate Hearing on Drug Prices
The top executives of three major companies appeared before a Senate panel led by Mr. Sanders, who has made lowering drug costs a signature issue.
The Race to Stop Ozempic Muscle Loss
Gym chains, nutrition startups and drugmakers all want to solve a common issue among people who take weight loss drugs.
What to Know About Mild Cognitive Impairment Treatment
There are ways to manage symptoms and slow the progression.
Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study
The patients used tirzepatide, sold as Mounjaro or Zepbound, but researchers could not distinguish the effect of the drug from the effects of weight loss.
Medicare Recipients Can Save on Drugs in 2024
Federal law set caps on some spending for seniors who are enrolled in Part D prescription drug plans. Those paying for high-cost medicines will benefit.
6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions
An array of obstacles makes it difficult for patients to obtain Wegovy or Zepbound. Finding Wegovy is “like winning the lottery,” one nurse practitioner said.
What Is a Yeast Infection? What to Know About Diagnosis and Treatment
There are plenty of effective solutions, experts say. But first you’ll need an accurate diagnosis.
U.S. Makes Initial Offers in Medicare Drug Price Negotiations
The offers amount to a starting gun in the price talks between the federal government and the makers of 10 prescription drugs that have been selected for negotiations.
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm
The pharmaceutical company will give up its ownership rights to the drug and stop a clinical trial that had been aimed at confirming whether it works.
The Man in Room 117
Andrey Shevelyov would rather live on the street than take antipsychotic medication. Should it be his decision to make?
Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs
Starting April 1, state employees in North Carolina will no longer have insurance coverage for costly weight-loss medications like Wegovy and Zepbound.
6 Paperbacks to Read This Week
Recommended reading from the Book Review, including titles by Geraldine Brooks, Jefferson Cowie, Parini Shroff and more.
Six Reasons Drug Prices Are So High in the U.S.
Research shows prices in the United States are nearly double those in other well-off countries.
El caso de Singulair, un medicamento para el asma que provocó angustia
Un medicamento contra el asma, que ya se consigue como genérico, todavía es usado por millones de personas en EE. UU., incluso después de que miles de pacientes y decenas de estudios han descrito sus
Un esperanzador experimento de ultrasonido para los tratamientos del cerebro
Algunos fármacos para tratar enfermedades como el alzhéimer o el cáncer se enfrentan a un obstáculo: la barrera hematoencefálica. Un ensayo en fases iniciales pretende resolver esa limitación.